Structural Basis of Type 2A von Willebrand Disease Investigated by Molecular Dynamics Simulations and Experiments

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Interlandi, Gianluca ^a   Ling, Minhua ^b   Tu, An Yue ^a   Chung, Dominic W ^b   Thomas, Wendy E ^a  

^a University of Washington   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ALPHA HELIX; ARTICLE; CARBOXY TERMINAL SEQUENCE; GENE MUTATION; MOLECULAR DYNAMICS; PREDICTION; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; PROTEIN UNFOLDING; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; VON WILLEBRAND DISEASE; WILD TYPE;

ADAM PROTEINS; CELL LINE; HUMANS; MOLECULAR DYNAMICS SIMULATION; PROTEIN STRUCTURE, SECONDARY; VON WILLEBRAND DISEASE, TYPE 2; VON WILLEBRAND FACTOR;

EID: 84867844824     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045207     Document Type: Article

References (50)

1. Ruggeri Z, (2004) Platelet and vonWillebrand factor interactions at the vessel wall. Ḧamostaseologie 24: 1-11.
2. Franchini M, Lippi G, (2006) Von willebrand factor and thrombosis. Ann Hematol 85: 415-423.
3. Savage B, Saldivar E, Ruggeri ZM (1996) Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von willebrand factor. Cell 84: 289-297. Interlandi, et al., Structural Basis of Type 2A VWD 15.
4. Yago T, Lou J, Wu T, Yang J, Miner JJ, et al. (2008) Platelet glycoprotein Ib_ forms catch bonds with human WT vWF but not with type 2B von Willebrand disease vWF. J Clin Invest 118: 3195-3207.
5. Interlandi G, Thomas W, (2010) The catch bond mechanism between von Willebrand Factor and platelets investigated by molecular dynamics simulations. Proteins: Structure, Function, and Bioinformatics 78: 2506-2522.
6. Arya M, Anvari B, Romo GM, Cruz AM, Dong JF, et al. (2002) Ultralarge multimers of vonWillebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood 99: 3971-3977.
7. Dent JA, Berkowitz SD, Ware J, Kasper C, Ruggeri ZM, (1990) Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor. Proc Natl Acad Sci USA 87: 6306-6310.
8. Lenting PJ, Pegon JN, Groot E, de Groot PG, (2010) Regulation of von Willebrand factor-platelet interactions. Thromb Haemostasis 104: 449-455.
9. Nishida H, Murata M, Miyaki K, Omae K, Watanabe K, et al. (2006) Gorog thrombosis test: analysis of factors influencing occlusive thrombus formation. Blood Coag Fibrin 17: 203-207.
10. Sadler J (2005) New concepts in Von Willebrand disease. Annu Rev Med 56: 173+.
11. Tsai H, (1996) Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood 87: 4235-4244.
12. Di Stasio E, De Cristofaro R, (2010) The effect of shear stress on protein conformation Physical forces operating on biochemical systems: The case of von Willebrand factor. Biophys Chemistry 153: 1-8.
13. Zhang Q, Zhou YF, Zhang CZ, Zhang X, Lu C, et al. (2009) Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor. Proc Natl Acad Sci USA 106: 9226-9231.
14. Zhang X, Halvorsen K, Zhang CZ, Wong WP, Springer TA, (2009) Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor. Science 324: 1330-1334.
15. Jakobi AJ, Mashaghi A, Tans SJ, Huizinga EG (2011) Calcium modulates force sensing by the von Willebrand factor A2 domain. Nat Commun 2: 385. Interlandi et al., Structural Basis of Type 2A VWD 16.
16. Wu T, Lin J, Cruz MA, Dong JF, Zhu C, (2010) Force-induced cleavage of single VWF A1A2A3 tridomains by ADAMTS-13. Blood 115: 370-378.
17. Matthew Auton MAC, Moake J, (2007) Conformational Stability and Domain Unfolding of the Von Willebrand Factor A Domains. J Mol Biol 366: 966-1000.
18. Enayat M, Guilliatt A, Surdhar G, Theopilus B, Hill F, (2000) A new candidate missense mutation (Leu 1657 IIe) in an apparently asymptomatic type 2A (phenotype IIA) von Willebrand disease family. Thromb Haemostasis 84: 369-373.
19. Iannuzzi M, Hidaka N, Boehnke M, Bruck M, Hanna W, et al. (1991) Analysis of the relationship of vonWillebrand disease (VWD) and hereditary hemorrhagic telangiectasia and identification of a potential type-IIA VWD mutation (Ile865 to Thr). Am J Hum Gen 48: 757-763.
20. Lyons S, Cooney K, Bockenstedt P, Ginsburg D, (1994) Characterization of Leu777Pro and Ile865Thr type IIA von-Willebrand disease mutations. Blood 83: 1551-1557.
21. Christophe O, Ribba A, Baruch D, Obert B, Rouault C, et al. (1994) Influence of mutations and size of multimers in type-II von-Willebrand disease upon the function of von-Willebrand-Factor. Blood 83: 3553-3561.
22. Ribba A, Voorberg J, Meyer D, Pannekoek H, Pietu G, (1992) Characterization of recombinant vonWillebrand-Factor corresponding to mutations in type-IIA and type-IIB vonWillebrand disease. J Biol Chem 267: 23209-23215.
23. Sousa SF, Cerqueira NMFSA, Fernandes PA, Ramos MJ, (2010) Virtual Screening in Drug Design and Development. Comb Chem High Throughput Screen 13: 442-453.
24. Interlandi G, Wetzel SK, Settanni G, Plueckthun A, Caflisch A, (2008) Characterization and further stabilization of designed ankyrin repeat proteins by combining molecular dynamics simulations and experiments. J Mol Biol 375: 837-854.
25. Kramer MA, Wetzel SK, Plueckthun A, Mittl PRE, Gruetter MG, (2010) Structural Determinants for Improved Stability of Designed Ankyrin Repeat Proteins with a Redesigned C-Capping Module. J Mol Biol 404: 381-391.
26. Chen W, Lou J, Zhu C (2009) Molecular Dynamics Simulated Unfolding of von Willebrand Factor A Domains by Force. Cell Mol Bioeng 2: 75-86. Interlandi, et al., Structural Basis of Type 2A VWD 17.
27. Sutherland JJ, O'Brien LA, Lillicrap D, Weaver DF, (2004) Molecular modeling of the von Willebrand factor A2 Domain and the effects of associated type 2A von Willebrand disease mutations. J Mol Model 10: 259-270.
28. Wu JJ, Fujikawa K, McMullen BA, Chung DW, (2006) Characterization of a core binding site for ADAMTS-13 in the A2 domain of von Willebrand factor. Proc Natl Acad Sci USA 103: 18470-18474.
29. Gao W, Anderson PJ, Sadler JE, (2008) Extensive contacts between ADAMTS13 exosites and von Willebrand factor domain A2 contribute to substrate specificity. Blood 112: 1713-1719.
30. Hassenpflug W, Budde U, Obser T, Angerhaus D, Drewke E, et al. (2006) Impact of mutations in the von Willebrand factor A2 domain on ADAMTS 13-dependent proteolysis. Blood 107: 2339-2345.
31. Gosse C, Croquette V, (2002) Magnetic tweezers: Micromanipulation and force measurement at the molecular level. Biophys J 82: 3314-3329.
32. Crawley JTB, de Groot R, Xiang Y, Luken BM, Lane DA, (2011) Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. Blood 118: 3212-3221.
33. Pos W, Crawley JTB, Fijnheer R, Voorberg J, Lane DA, et al. (2010) An autoantibody epitope comprising residues R660, Y661, and Y665 in the ADAMTS13 spacer domain identifies a binding site for the A2 domain of VWF. Blood 115: 1640-1649.
34. Jin SY, Skipwith CG, Zheng XL, (2010) Amino acid residues Arg(659), Arg(660), and Tyr(661) in the spacer domain of ADAMTS13 are critical for cleavage of von Willebrand factor. Blood 115: 2300-2310.
35. de Groot R, Bardhan A, Ramroop N, Lane DA, Crawley JTB, (2009) Essential role of the disintegrin-like domain in ADAMTS13 function. Blood 113: 5609-5616.
36. Zanardelli S, Chion ACK, Groot E, Lenting PJ, McKinnon TAJ, et al. (2009) A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF. Blood 114: 2819-2828.
37. Luken BM, Winn LYN, Emsley J, Lane DA, Crawley JTB (2010) The importance of vicinal cysteines, C1669 and C1670, for von Willebrand factor A2 domain function. Blood 115: 4910-4913. Interlandi, et al., Structural Basis of Type 2A VWD 18.
38. Zhou M, Dong X, Baldauf C, Chen H, Zhou Y, et al. (2011) A novel calcium-binding site of von Willebrand factor A2 domain regulates its cleavage by ADAMTS13. Blood 117: 4623-4631.
39. Xu AJ, Springer TA, (2012) Calcium stabilizes the von Willebrand factor A2 domain by promoting refolding. Proc Natl Acad Sci USA 109: 3742-3747.
40. Drews RE, Shulman LN, (2010) Update in Hematology and Oncology. Ann IntMed 152: 655-W229.
41. Brooks BR, Brooks CL III, Mackerell AD Jr, Nilsson L, Petrella RJ, et al. (2009) CHARMM: The Biomolecular Simulation Program. J Comput Chem 30: 1545-1614.
42. Kaĺe L, Skeel R, Bhandarkar M, Brunner R, Gursoy A, et al. (1999) NAMD2: Greater scalability for parallel molecular dynamics. Journ Comp Physics 151: 283-312.
43. MacKerell A, Bashford D, Bellott M, Dunbrack R, Evanseck J, et al. (1998) All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102: 3586-3616.
44. Darden T, York D, Pedersen L, (1993) Particle mesh ewald - an N. log(N) method for ewald sums in large systems. J Chem Phys 98: 10089-10092.
45. Schneider T, Stoll E, (1978) Molecular-Dynamics study of a 3-dimensional one-component model for distortive phase-transitions. Physical Review B 17: 1302-1322.
46. Feller SE, Zhang YH, Pastor RW, Brooks BR, (1995) Constant-pressure molecular-dynamics simulation - the Langevin piston method. Journal of chemical physics 103: 4613-4621.
47. Mize GJ, Harris JE, Takayama TK, Kulman JD, (2008) Regulated expression of active biotinylated G-protein coupled receptors in mammalian cells. Protein Expression Purif 57: 280-289.
48. Chen J, Fu X, Wang Y, Ling M, McMullen B, et al. (2010) Oxidative modification of vonWillebrand factor by neutrophil oxidants inhibits its cleavage by ADAMTS13. Blood 115: 706-712.
49. Humphrey W, Dalke A, Schulten K, (1996) Vmd: Visual molecular dynamics. J Molec Graphics 14: 33-38.
50. Willis B, Pryor A (1975) Thermal vibrations in crystallography. London; New York: Cambridge Univ. Press.